Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06270355
PHASE3

Stockholm Mammography Risk Stratified Trial

Sponsor: Karolinska Institutet

View on ClinicalTrials.gov

Summary

SMART is a Phase III, randomised, non-blinded screening trial. Women who consent to participate in SMART are randomised to either individualised screening or screening according to the Swedish National Breast Cancer Screening Program. Women randomised to individualised screening get their 2-year risk of breast cancer assessed and women with the highest short-term risk are offered contrast enhanced mammography and a mammogram at 12 months.

Key Details

Gender

FEMALE

Age Range

40 Years - 74 Years

Study Type

INTERVENTIONAL

Enrollment

70000

Start Date

2024-04-08

Completion Date

2032-04-08

Last Updated

2024-02-28

Healthy Volunteers

Yes

Conditions

Interventions

PROCEDURE

Risk based screening

Women randomised to the individualised screening arm and judged to be at high risk will be invited to a contrast enhanced mammography and a mammography after 12 months. The intervention is thus a different selection of women compared to what is done today.